Vikas Lifecare Limited has announced that its Board of Directors will convene on April 11, 2026, to discuss critical business matters including growth strategy and fund raising initiatives. The meeting, scheduled to be held at the company's registered office, will address multiple strategic aspects of the company's operations and future plans.

Meeting Agenda and Strategic Focus

The board meeting has been organized to consider and deliberate upon several key areas that will shape the company's trajectory. The primary focus areas include comprehensive business strategy discussions, growth planning for the current fiscal year, and evaluation of fund raising proposals.

Fund Raising Through Securities Issuance

A significant component of the board's deliberations will center on proposals for raising funds through the issuance of securities. The company plans to explore various permissible modes for securities issuance, indicating a strategic approach to capital mobilization. This initiative aligns with the company's broader business plans and growth objectives for the current fiscal year.

Trading Window Restrictions

In accordance with regulatory requirements, Vikas Lifecare Limited has implemented trading window restrictions affecting key stakeholders. The trading window for dealing in the company's securities remains closed for specific categories of individuals, ensuring compliance with insider trading regulations.

Regulatory Compliance

The board meeting announcement has been made in strict compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where material matters will be discussed. The company has duly notified both the National Stock Exchange of India Limited and BSE Limited about the scheduled meeting, ensuring transparency and regulatory adherence.

Vikas Lifecare Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The certificate was filed with both the National Stock Exchange of India Limited and BSE Limited on April 06, 2026, as part of the company's regulatory compliance obligations.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Managing Director Sundeep Kumar Dhawan (DIN: 09508137) signed the compliance document on behalf of the company.

Registrar Confirmation

Bigshare Services Pvt Ltd, serving as the company's registrar and transfer agent, provided confirmation regarding dematerialization activities during the quarter. The registrar confirmed that no dematerialization requests were received from shareholders during the period from January 01, 2026 to March 31, 2026.

Company Information

Vikas Lifecare Limited operates as a listed entity on both NSE and BSE with the symbol VIKASLIFE and scrip code 542655 respectively. The company maintains its registered office at Vikas House, 3, Arihant Nagar, Punjabi Bagh West, New Delhi, and operates manufacturing facilities in Rajasthan and Karnataka.

The submission of this quarterly certificate demonstrates the company's adherence to SEBI's regulatory framework for depositories and participants, ensuring transparency in securities transactions and maintaining compliance with stock exchange listing requirements.